Abstract
Various research has shown that non-melanocytic malignant skin lesion is one of the most common post-kidney transplant neoplasms. Multiple lesions and a more aggressive clinical course are more common in kidney transplant patients than in the general population. This paper presents a case of malignant skin neoplasms in a patient 10 years after cadaveric kidney transplantation. The patient received standard 3-component immunosuppression with satisfactory graft function (serum creatinine level remained at 157–178 μmol/L). Scalp neoplasm was removed. Histological examination revealed a morphological picture characteristic of basal cell carcinoma with squamous differentiation. Subsequently, a relapse of the skin neoplasm of the temporal region, as well as new lesions in the frontal region and the skin of the anterior chest wall, were discovered. Despite surgical treatment and close-focus x-ray radiation, the disease rapidly progressed and eventually led to death. Squamous cell carcinoma can progress very rapidly in patients after solid organ transplantation, despite ongoing combination treatment. Perhaps in such cases, it is worth cancelling immunosuppressive therapy completely and removing the kidney graft in order to control progression of the malignant tumor process.
Highlights
Various research has shown that non-melanocytic malignant skin lesion is one of the most common post-kidney transplant neoplasms
Multiple lesions and a more aggressive clinical course are more common in kidney trans‐ plant patients than in the general population
This paper presents a case of malignant skin neoplasms in a patient 10 years after cadaveric kidney transplantation
Summary
Various research has shown that non-melanocytic malignant skin lesion is one of the most common post-kidney transplant neoplasms. This paper presents a case of malignant skin neoplasms in a patient 10 years after cadaveric kidney transplantation. E-mail: indymkov@bk.ru For correspondence: Dymkov Ivan Nikolaevich. Squamous cell carcinoma can progress very rapidly in patients after solid organ transplantation, despite ongoing combination treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Russian Journal of Transplantology and Artificial Organs
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.